A Study Evaluating the Safety of the Nasal Pump
A Phase 4, Single-Center, Open-Label Study Evaluating the Safety of the Tyrvaya Nasal Pump
Sponsor: Oyster Point Pharma, Inc.
Terminated
Internal strategy change. Not related to safety concerns.
Listed as NCT06329687, this PHASE4 trial focuses on Dry Eye and Kerato Conjunctivitis Sicca and remains terminated or withdrawn. Sponsored by Oyster Point Pharma, Inc., it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Jun 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
May 2024 — Jul 2024 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Apr 2024 — May 2024 [monthly]
Active Not Recruiting PHASE4
First recorded
Feb 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oyster Point Pharma, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .